04.01.2014 Views

Broker-Dealer Litigation - Greenberg Traurig LLP

Broker-Dealer Litigation - Greenberg Traurig LLP

Broker-Dealer Litigation - Greenberg Traurig LLP

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

pursuant to Rule 10b5-1, they would not be held liable for insider trading. The court held that<br />

the defendants traded stock solely based on their 10b5-1 plans, which were in effect prior to any<br />

known errors on the company’s financial statements. Accordingly, the court granted defendants’<br />

motion to dismiss.<br />

Applestein v. Medivation, Inc., 2011 WL 3651149 (N.D. Cal. Aug. 18, 2011).<br />

C.1.f<br />

Plaintiffs filed a securities class action against defendants based on violations of Section<br />

10(b) and Rule 10b-5 of the Securities Exchange Act of 1934 by making misleading<br />

representations related to the results of a clinical trial for a drug. In support of their claim,<br />

plaintiffs argued that insider trading allegedly perpetrated by corporate officers was indicative of<br />

scienter for the claims under the Securities Exchange Act of 1934. Defendants, in their motion<br />

to dismiss, argued the affirmative defense that any trading done on their behalf was pursuant to<br />

Rule 10b5-1 plans. Such plans are a predetermined plan or contract to trade in stock created prior<br />

to becoming aware of material non-public information. However, the court concluded that<br />

defendants could not claim the defense under Rule 10b5-1 because plaintiffs alleged that the<br />

plans were adopted by the individual defendants after they knew of the inside information.<br />

Nonetheless, the court determined that plaintiffs failed to adequately plead facts giving rise to an<br />

inference of scienter, and dismissed the complaint without prejudice.<br />

Curry v. Hansen Medical, Inc., 2011 WL 3741238 (N.D. Cal. Aug. 25, 2011).<br />

C.1.f.<br />

Plaintiffs, who purchased or acquired common stock in defendant corporation, brought a<br />

class action against defendants alleging violations of Rule 10b-5 and Section 10(b) of the<br />

Securities Exchange Act of 1934. Plaintiffs alleged that defendants induced plaintiffs to<br />

purchase common stock at artificially inflated prices by making intentional misstatements<br />

regarding defendant corporation’s revenue recognition and sales performance. In particular,<br />

plaintiffs asserted that defendants specifically indicated that the company had seen four<br />

successive quarters of increasing sales. Defendants moved to dismiss the complaint on the basis<br />

that the complaint failed to allege securities fraud with sufficient particularity. The court, in<br />

evaluating whether the statements were forward-looking statements protected by the safe harbor<br />

provision of the Private Securities <strong>Litigation</strong> Reform Act of 1995 (“PSLRA”), found that<br />

statements of present or historical fact are not protected. Accordingly, references to concrete<br />

rates of sales and user activity were not protected by the safe harbor provision as statements of<br />

present or historical fact. However, the court held that the plaintiffs failed to adequately allege<br />

that the defendants made the statements with knowledge of the alleged falsity. Accordingly, and<br />

for other reasons, the Court granted defendants’ motion to dismiss and found that plaintiffs failed<br />

to adequately plead the misstatements were made with the requisite knowledge.<br />

92

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!